BECTON DICKINSON & CO ($BDX)
Filing Information
| Accession Number | 0001944816-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
10,172
Total Value
$1,359,688.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Pres Med.Essntl&BioPharm | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 3,054 | $167.91 | $512,797.14 | 16,159 | Direct | โ | View Details | |
EVP & Pres Med.Essntl&BioPharm | Common Stock | โ | Jan 15, 2026 | Sale to Issuer | 2,454 | $209.00 | $512,886.00 | 13,705 | Direct | โ | View Details | |
EVP & Pres Med.Essntl&BioPharm | Common Stock | โ | Jan 15, 2026 | Sale | 600 | $209.00 | $125,400.00 | 13,105 | Direct | โ | View Details | |
EVP & Pres Med.Essntl&BioPharm | Common Stock | โ | Jan 15, 2026 | Sale | 1,010 | $206.54 | $208,605.40 | 12,095 | Direct | โ | View Details | |
EVP & Pres Med.Essntl&BioPharm | Stock Appreciation Rights | Derivative | Jan 15, 2026 | Exercise/Conversion | 3,054 | $0.00 | $0.00 | 0 | Direct | โ | View Details |